United posts positive data for inhaled PAH drug
This is a discussion on United posts positive data for inhaled PAH drug within the Biotechnology News forum, part of the Industry News and Updates category; United Therapeutics shares were on the rise after the company announced positive results from a Phase III trial of Viveta, ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
05-23-2008, 04:06 PM
|
|||
|
|||
United posts positive data for inhaled PAH drug
United Therapeutics shares were on the rise after the company announced positive results from a Phase III trial of Viveta, an inhaled version of pulmonary arterial hypertension (PAH) drug Remodulin. Read more...
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Roche posts new data backing Actemra for RA | industry_news | Biotechnology News | 0 | 05-12-2008 02:37 PM |
| Renovo reports positive Juvista data | industry_news | Biotechnology News | 0 | 04-22-2008 03:11 PM |
| Introgen gets positive Phase III Advexin data | industry_news | Biotechnology News | 0 | 04-15-2008 02:27 PM |
| Alkermes: Lilly may dump inhaled insulin program | industry_news | Biotechnology News | 0 | 03-07-2008 03:03 PM |
© 2008 DrugManagementForum™ powered by |
 |